2186 — Luye Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- HK$7.52bn
- HK$13.29bn
- CNY6.06bn
- 24
- 76
- 18
- 31
Annual cashflow statement for Luye Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 942 | -74.6 | 670 | 700 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 371 | 661 | 455 | 399 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -791 | -986 | -142 | -206 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,033 | 182 | 1,654 | 1,595 | — |
| Capital Expenditures | -1,520 | -1,542 | -1,164 | -1,165 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,658 | -1,894 | -495 | -253 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 138 | -3,436 | -1,658 | -1,418 | — |
| Financing Cash Flow Items | -933 | 1,241 | 720 | 397 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 254 | 1,879 | 54.1 | 842 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,538 | -1,427 | -115 | 915 | — |